BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7478576)

  • 1. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
    Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
    Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shc products are substrates of erbB-2 kinase.
    Segatto O; Pelicci G; Giuli S; Digiesi G; Di Fiore PP; McGlade J; Pawson T; Pelicci PG
    Oncogene; 1993 Aug; 8(8):2105-12. PubMed ID: 8101647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
    Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
    Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein.
    Saxton TM; van Oostveen I; Bowtell D; Aebersold R; Gold MR
    J Immunol; 1994 Jul; 153(2):623-36. PubMed ID: 8021500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
    Thomas D; Bradshaw RA
    J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
    Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
    Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
    J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
    Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
    Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
    van der Geer P; Wiley S; Gish GD; Pawson T
    Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
    Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
    Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
    Curto M; Frankel P; Carrero A; Foster DA
    Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuregulin-increased expression of acetylcholine receptor epsilon-subunit gene requires ErbB interaction with Shc.
    Won S; Si J; Colledge M; Ravichandran KS; Froehner SC; Mei L
    J Neurochem; 1999 Dec; 73(6):2358-68. PubMed ID: 10582594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
    Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
    J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
    Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
    J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.